Stay updated on Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.

Latest updates to the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedThe record history now includes a recruitment status update indicating no further participant enrollment, and a new revision entry (v3.6.0) alongside the removal of a previous revision (v3.5.5).SummaryDifference0.2%

- Check10 days agoChange DetectedA new Revision: v3.5.5 entry was added to the history and the previous Revision: v3.5.4 was removed, updating the page's version history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study record gains updated Study Status and Contacts/Locations sections. These changes reflect the current status and contact details for the trial.SummaryDifference0.3%

- Check32 days agoChange DetectedA new revision entry, Revision: v3.5.4, is added to the Record History, replacing Revision: v3.5.3. This entry reflects an update to the record's version history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record was updated so the trial’s status changed from “Active, not recruiting” to “Completed,” with corresponding recruitment status changes. This reflects that the study is no longer recruiting and has reached completion.SummaryDifference0.4%

- Check60 days agoChange DetectedNew revision v3.5.2 was added and the previous revision v3.5.0 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.